Find Clinical Trials & Studies

OPTIMIZER Smart Post Approval Study

I'm Interested!
Please call
1-833-78TRIAL

Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy (PAS)

  • Sex: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Interventional / Therapeutic
  • Trial Phase: Phase IV
  • Conditions Being Studied: Heart Failure

Study Purpose

The purpose of this post approval study (PAS) is to evaluate the safety of long-term use of the OPTIMIZER Smart and called cardiac contractility modulation (CCM) therapy. The PAS will also evaluate the effects of CCM therapy on quality of life and heart failure symptoms, as well as the hearts ability to pump effectively (echo) and some potential blood related chemical changes.

Who Can Participate

Age: 18 and older

Principal Investigator
Ivan Cakulev MD
Department/Division
Heart and Vascular (Electrophysiology)

Locations

UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106

  • UH IRB: SITE00001278
  • StudyID: 2020-0371
  • ClinicalTrials.gov: NCT03970343
I'm Interested!
Please call
1-833-78TRIAL

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL

Cancer Trials: 1-866-373-1464